Ginkgo Bioworks designs custom microbes for customers across multiple markets, developing new organisms that replace technology with biology.

Biotechnology

Education

Ginkgo Bioworks

Ryan Carrithers is the current Vice President at [Ginkgo Bioworks](/org/ginkgo-bioworks). Prior to this, they served as the VP of Finance, Treasury and IR at Astra from January 2020 to November 2022. Ryan has also served as the Chief Financial Officer for both [KUKA](/org/kuka) North America and [Comau](/org/comau-s-p-a). Ryan began their career in 2004 as a Senior Financial Controller at Bosch USA before moving to [Comau](/org/comau-s-p-a) in 2010 as their Corporate Financial Controller. In 2012, they became the Group Financial Controller for [KUKA](/org/kuka) North America before being promoted to Chief Financial Officer - South America in October of that year. In 2018, they were again promoted to Chief Financial Officer - Automotive Americas and held that position until January 2020 when they left to join Astra.

Ryan Carrithers pursued a Bachelor of Science at [Kettering University](/org/kettering-university) in the field of accounting and economics.

Ryan Carrithers

Marnix Hollander is the current Vice President of Sales & Operations Planning at [Ginkgo Bioworks](/org/ginkgo-bioworks). Prior to this, they served as Vice President of Industry Manufacturing Solutions at o9 Solutions, Inc. from October 2021 to November 2022. From January 2019 to September 2021, they were an Associate Partner and Senior Solution Leader at [McKinsey & Company](/org/mckinsey-company). Marnix also served as a Solution Leader and Associate Partner at [McKinsey & Company](/org/mckinsey-company) from June 2016 to December 2018, and as an Engagement Manager from September 2014 to June 2016. Hollander began their career at [McKinsey & Company](/org/mckinsey-company) as an Associate from September 2012 to September 2014. Marnix then co-founded [Podimetrics](/org/podimetrics) in April 2012 and served as its Co-Founder until September 2012. Hollander also worked as an LGO Fellow at Amgen Inc. from June 2011 to December 2011. Prior to that, they were the Co-Founder of PolyChroma Inc. from September 2010 to December 2011. Marnix started their career as a Design and Development Engineer at MagCanica Inc. from August 2007 to May 2010, and then worked as a Developer / Technical Writer at Axioma Inc. from May 2006 to August 2006. Hollander founded BanzaiDesigns Inc. in September 2004 and served as its President until August 2007.

Marnix Hollander has a MS from Massachusetts Institute of Technology and an MBA from Columbia Engineering.

Marnix Hollander

Patrick Jamieson is the Vice President of Transformations at [Ginkgo Bioworks](/org/ginkgo-bioworks). Prior to this role, they served as the Vice President of Strategy & Corporate Development at [Motional](/org/motional) from December 2019 to November 2022. Patrick also served as a Board Observer at KRONO-SAFE from October 2019 to March 2020 and [Affectiva](/org/affectiva) from January 2019 to March 2020. In addition, Jamieson was the Director of Strategic Investments at [Aptiv](/org/aptiv) from April 2018 to December 2019. Patrick began their career at GSK as the Director, Business Development & Licensing from June 2016 to April 2018. Patrick then became the Associate Director, Business Development & Licensing from July 2014 to June 2016. Prior to GSK, Jamieson worked as the Manager, Business Development & Licensing at Novartis Consumer Health from June 2013 to July 2014. Patrick also served as the Segment Finance Manager at [Thermo Fisher Scientific](/org/thermo-fisher-scientific) from August 2011 to June 2013. Jamieson began their career at [Thermo Fisher Scientific](/org/thermo-fisher-scientific) as a Finance Associate (Financial Leadership Development Participant) from June 2009 to August 2011.

Patrick Jamieson has a Bachelor of Science in Economics-Finance from [Bentley University](/org/bentley-university), a Negotiation for Executives certificate from MIT Sloan Executive Education, and a Bachelor of Science in Economics-Finance from [Copenhagen Business School](/org/copenhagen-business-school).

Patrick Jamieson

Magalie Guilhabert is currently the VP and Head of Agriculture at [Ginkgo Bioworks](/org/ginkgo-bioworks). Prior to this, they worked at [Bayer](/org/bayer) for over five years in various microbial research positions. Magalie has a passion for developing new technologies to improve crop efficiency and seed growth. VP, has led teams of scientists responsible for identification and optimization of new active ingredients, data science, biomanufacturing, microbial genetics, chemistry, and discovery. Magalie holds a degree in microbiology from the University of California, Davis.

The educational career for VP, Head of Agriculture would be as follows: a [Bayer](/org/bayer) Digital Transformation Program at IMD Business School, an Executive Data Science at The Johns Hopkins University, a Senior Manager Program at University of Notre Dame Business School, a Research and Development Strategy at [INSEAD](/org/insead), a PhD in Plant Pathology at University of California, Davis, a Master in Biology/Plant Breeding at Université de Rennes I, and finally a BS in Molecular and Cellular Biology from University de Tours.

VP, Head of Agriculture works with Jennifer Wipf - SVP, Commercial Cell Engineering, Susan A. Miele - Chief People Officer, and Adithya Yaga - Head of Transformation. VP, Head of Agriculture reports to Jason Kelly, Co-Founder & CEO.

VP, Head of Agriculture

Kevin Wright is the current VP of Continuous Improvement & Industrial Engineering at [Ginkgo Bioworks](/org/ginkgo-bioworks). Kevin has previously worked as the Global Director Operational Excellence & Chief of Staff at [Merck](/org/merck) from September 2018 to October 2022, and as the Director of Supply Chain and Director of Operational Excellence at Teva Pharmaceuticals from February 2016 to September 2018 and March 2015 to February 2016, respectively. Kevin has also held the position of Associate Director, Operational Excellence - Quality at Teva Pharmaceuticals from September 2013 to March 2015.

Kevin Wright has a MS in Biotechnology from The Johns Hopkins University, an MBA in Business from Liberty University, and a BS in Biology/Chemistry from the University of Lynchburg. Kevin also has a certification from the [Project Management Institute](/org/project-management-institute) as a Project Management Professional (PMP).

They are on a team with Tomer Stavitsky - VP, Corporate Development, Head of M&A, Adithya Yaga - Head of Transformation, and Kevin Madden - SVP, Platform Commercialization. Kevin Wright reports to Jason Kelly, Co-Founder & CEO.

Kevin Wright

Dr. Kewalramani has dedicated her career to improving the lives of patients, including the last fifteen years working on the development of new medicines. She joined Vertex in 2017 and was previously their Chief Medical Officer and Executive Vice President of Global Medicines Development and Medical Affairs. During that time, Vertex made remarkable progress to bring new medicines to more cystic fibrosis patients around the world, including the rapid approval of medicines to potentially treat up to 90% of all CF patients. Under her leadership, Vertex also advanced several programs outside of CF into the clinic, including programs in cell and gene therapies. Prior to Vertex, Dr. Kewalramani spent more than 12 years at Amgen where she held a variety of roles across Research and Development.

Dr. Kewalramani is a member of the Massachusetts General Hospital Board of Trustees, the Biomedical Science Careers Program Board and the Boston University School of Medicine Dean's Advisory Board. She was the 2019 recipient of the TiE Boston Healthcare Leadership Award and the 2021 recipient of the International Institute of New England's Golden Door Award.

Reshma Kewalramani

Birgitte Simen is the current Vice President of Biosecurity Technical Platforms at [Ginkgo Bioworks](/org/ginkgo-bioworks). Birgitte has over 17 years of experience in the field of biomedical science and next-generation sequencing. 

Simen started their career as a postdoctoral student at [Yale University](/org/yale-university), where they worked on developing assays and robustness studies on sequencing HIV and HLA targets. In 2006, they joined 454 Life Sciences/Roche as a group leader. During their time at 454 Life Sciences/Roche, they were the project lead for Roche Leukemia Assay kits, which were launched in 2012. In 2011, they were promoted to Director, where they oversaw eight reports in two levels. 

In 2013, Simen left 454 Life Sciences/Roche to start their own biomedical consulting company, Simen Biomedical Consulting. Birgitte provided consulting services to universities and corporations focused on assay development and validation under CLIA/CAP guidelines. In 2014, they joined [Veritas Genetics](/org/veritas-genetics) as Vice President of Product Development. During their time at [Veritas Genetics](/org/veritas-genetics), they oversaw Roche HLA Sequencing kits launched in March 2011 as project lead and was the technical lead for Titanium Series Amplicon Sequencing kits launched in October 2009. Birgitte also coordinated three international inter-laboratory robustness studies on sequencing HIV and HLA targets. 

Simen joined [Ginkgo Bioworks](/org/ginkgo-bioworks) in August 2019 as VP, Biosecurity Technical Platform

Birgitte Simen has a Ph.D. in Cell Physiology from the University of Chicago and an M.Sc. in Molecular Immunology and B.Sc. in Biochemistry from Københavns Universitet - University of Copenhagen.

Birgitte Simen reports to Chris Mellen, Chief Information Security Officer.

Birgitte Simen

Matthew F. McKnight is the current General Manager of Biosecurity at [Ginkgo Bioworks](/org/ginkgo-bioworks). Prior to their current position, McKnight held various other positions at different companies. These companies include: [SmithRx](/org/smithrx), Searchlight Health, [Decision Resources Group](/org/context-matters), IndUS Growth Partners, Palantir Technologies, and US Marine Corps. 

McKnight's first position was as a Business Development Consultant at Palantir Technologies from February 2010 to March 2012. Matthew then became an Active Duty member of the US Marine Corps from May 2005 to June 2009. After their time in the military, McKnight became a Partner at IndUS Growth Partners from April 2011 to January 2018. Matthew also served as a Board Observer for [Decision Resources Group](/org/context-matters) from September 2012 to July 2019 and as a Member of the Board for Searchlight Health from May 2015 to August 2019. McKnight assumed their current role as General Manager of Biosecurity at [Ginkgo Bioworks](/org/ginkgo-bioworks) in 2019.

Matthew F. McKnight's educational career includes a Bachelor of Arts from Dartmouth College in Matthew'story and Government with a minor, a Master of Business Administration from [Harvard Business School](/org/harvard-business-school), and a Master in Public Policy from Harvard Kennedy School.

Their manager is Jason Kelly, Co-Founder & CEO. Matthew F. McKnight works with Reshma Shetty - Co-Founder, Anna Marie Wagner - SVP, Corporate Development, and Adithya Yaga - Head of Transformation.

Matthew F. McKnight

Ena Cratsenburg is the current Chief Business Officer at [Ginkgo Bioworks](/org/ginkgo-bioworks). Ena has also held previous positions at Verb Biotics LLC, [Ginkgo Bioworks](/org/ginkgo-bioworks), Inc., Intrexon Corporation, Evolva SA, [Amyris](/org/amyris), [Pixar](/org/pixar-inc), BP, and Ayana Bio. 

Ena Cratsenburg has over 20 years of experience in business development and distribution/logistics. Ena has a proven track record in developing and commercializing products that improve the lives of consumers. 

Ena Cratsenburg has a Bachelor of Science degree in Chemical Engineering from the [University of Colorado Boulder](/org/university-of-colorado-boulder).

Ena Cratsenburg has a MBA in Economics, Strategy & Marketing from Northwestern University - Kellogg School of Management and a B.S. in Chemical Engineering from the University of Illinois Urbana-Champaign.

Some individuals on their team include Jess Leber - VP, Business Development, Kalpesh Parekh - VP, Business Development, and Angela Carisa Ailloni - VP, Business Development. Some of their coworkers include Susan A. Miele - Chief People Officer, Kevin Madden - SVP, Platform Commercialization, and Matthew F. McKnight - General Manager, Biosecurity. Ena Cratsenburg reports to Jason Kelly, Co-Founder & CEO.

Ena Cratsenburg

Karen Tepichin is the General Counsel at [Ginkgo Bioworks](/org/ginkgo-bioworks). Karen was previously a Partner at Foley Hoag LLP, where they advised public and private companies in the life sciences and technology industries in strategic transactions, focusing on licensing and collaboration arrangements, option agreements, material transfers, research agreements and supply and distribution agreements. Karen also contributed to the development of clients' best practices and standard form agreements in these areas.

Prior to their time at Foley Hoag, Karen was an Associate at Ropes & Gray LLP. Karen also worked as a Teaching Fellow in Economics at [Harvard University](/org/harvard) and as a Research Assistant at Harvard School of Public Health.

Karen Tepichin received their Juris Doctor from Harvard Law School and their Bachelor of Science from [Duke University](/org/duke-university) in Biology and Economics. Karen is licensed to practice law in the state of Texas and is certified by the Massachusetts Board of Bar Overseers.

Karen Tepichin reports to Jason Kelly, Co-Founder & CEO. Some of their coworkers include Kevin Madden - SVP, Platform Commercialization, Anna Marie Wagner - SVP, Corporate Development, and Jennifer Wipf - SVP, Commercial Cell Engineering.

Karen Tepichin

Mark Dmytruk is the CFO at [Ginkgo Bioworks](/org/ginkgo-bioworks). Mark has over 20 years of experience in the biopharmaceutical industry, including stints as EVP of Corporate Strategy & Development at [Syneos Health](/org/syneos-health) and as a senior executive at INC Research/inVentiv Health. Dmytruk has a proven track record in developing and executing corporate strategy, overseeing operations, and leading change management initiatives. Mark is a strategic thinker with a strong ability to identify opportunities and drive growth. Under their leadership, [Syneos Health](/org/syneos-health) has become a leading biopharmaceutical solutions provider with a global reach.

Mark Dmytruk has an MBA from the MIT Sloan School of Management and a Bachelor of Commerce from the [University of Alberta](/org/university-of-alberta).

Some of their coworkers include Adithya Yaga - Head of Transformation, Reshma Shetty - Co-Founder, and Karen Tepichin - General Counsel. Mark Dmytruk reports to Jason Kelly, Co-Founder & CEO. Marie Fallon - Chief Accounting Officer, Aaron Huber - VP, Strategic Finance report to Mark Dmytruk.

Mark Dmytruk

Laura Bronner is the current VP of Commercial at [Ginkgo Bioworks](/org/ginkgo-bioworks). Laura has also served as the COO of Little Sprouts, LLC from October 2020 to January 2021. At Little Sprouts, Laura was responsible for moving the company forward strategically while also maintaining essential safety best practices. Laura also built and began to execute a strategy to deliver profitable operations by analyzing the company's current state, assessing opportunities for improvement, and innovating to ensure predictable, repeatable, and scalable results. Laura is an experienced leader with a proven track record of success in both operational and human resources management.

Laura Bronner has an MBA from Northwestern University - Kellogg School of Management and a BA from [Duke University](/org/duke-university). Laura also has a bachelor's degree from Highland Park High School.

Their manager is Kevin Madden, SVP, Platform Commercialization.

Laura Bronner

Maura Sullivan is the VP of Operations at [Ginkgo Bioworks](/org/ginkgo-bioworks). Maura has also worked as a Senior Fellow at New Politics, CEO of Warrior-Scholar Project, and a candidate for Congress in New Hampshire's 1st Congressional District. Prior to that, they were the Senior Vice President of Operations at 2020 On-site and also worked at the United States Department of Defense as the Special Assistant to the Secretary of the Navy and as the Assistant Secretary for Public & Intergovernmental Affairs at the [U.S. Department of Veterans Affairs](/org/u-s-department-of-veterans-affairs). Maura began their career as a Zone Director at [PepsiCo](/org/pepsico) and later served as a Captain in the United States Marine Corps.

Maura Sullivan was educated at [Harvard Business School](/org/harvard-business-school), Harvard Kennedy School, and [Northwestern University](/org/northwestern-university). Maura has a Bachelor of Arts in Economics and Maura'story from [Northwestern University](/org/northwestern-university). Maura also has a Master of Business Administration and a Master of Public Administration from [Harvard University](/org/harvard).

Maura Sullivan reports to Jason Kelly, Co-Founder & CEO. Maura Sullivan works with Mark Dmytruk - CFO, Jennifer Wipf - SVP, Commercial Cell Engineering, and Matthew F. McKnight - General Manager, Biosecurity.

Maura Sullivan

Kevin Madden is currently the SVP of Platform Commercialization at [Ginkgo Bioworks](/org/ginkgo-bioworks). Kevin has over 20 years of experience in the biotech industry, having served in various technical leadership roles at [Ironwood Pharmaceuticals](/org/ironwood-pharmaceuticals), Millennium Pharmaceuticals, and Microbia, Inc. Kevin has a Ph.D. in Biology from MIT and was a Post-Doctoral Fellow at Millennium Pharmaceuticals before joining the industry.

Kevin Madden has a PhD in Biology from [Yale University](/org/yale-university) and a BA in Biology from the [University of Pennsylvania](/org/university-of-pennsylvania).

and Laura Bronner - VP, Commercial reports to Kevin Madden. They work with Chris Mellen - Chief Information Security Officer, Matthew F. McKnight - General Manager, Biosecurity, and Maura Sullivan - VP, Operations. Kevin Madden reports to Jason Kelly, Co-Founder & CEO.

Kevin Madden

Jason Kelly is the co-founder and CEO of [Ginkgo Bioworks](/org/ginkgo-bioworks). Jason was previously the founder of OpenWetWare, which they founded while a graduate student at MIT. Jason has a passion for making biology easier to engineer and enabling access to tools and information for scientists.

Jason Kelly has a PhD in Biological Engineering from the Massachusetts Institute of Technology. Jason also has a B.S. in Biology & Chemical Engineering from the same school.

Some direct reports include Chris Mellen - Chief Information Security Officer, Greg LoConte - VP, Head of Infrastructure Operations, and Mark Dmytruk - CFO.

Jason Kelly

Christian Henry is the current director at [Ginkgo Bioworks](/org/ginkgo-bioworks). Prior to this, they held various executive positions at companies such as Wave Life Sciences, [Illumina](/org/illumina), [Tickets.com](/org/tickets-com), and Affymetrix. Christian has also served as a corporate controller at [Nektar Therapeutics](/org/nektar-therapeutics). Henry has experience in fields such as sales, marketing, product development, informatics, and finance.

Christian Henry has a BA in Biochemistry/Cell Biology from [UC San Diego](/org/uc-san-diego) and an MBA in Finance from the University of California, Irvine - The Paul Merage School of Business.

Christian Henry

Anna Marie Wagner is the SVP of Corporate Development at [Ginkgo Bioworks](/org/ginkgo-bioworks). Anna has over eight years of experience as a private equity investor, focusing on technology and consumer/retail companies. 

Wagner began their career at [Bain Capital](/org/bain-capital) in 2011. There, they gained extensive experience in due diligence, portfolio operations, deal structuring, execution, and financing. Some of their notable investments include Central Square Technologies, [Apple Leisure Group](/org/apple-leisure-group), Travel Impressions, CheapCaribbean.com, and Jupiter Shop Channel. 

In addition to their investment responsibilities, Wagner has also taken on various operational roles at portfolio companies. These have included acting as a partner to the CEO and executive team at [Rocket Software](/org/rocket-software), conducting due diligence and executing add-on acquisitions at [Apple Leisure Group](/org/apple-leisure-group), and leading strategic initiatives at Michaels Stores and [Gymboree](/org/gymboree). 

Wagner has also been involved in several high-profile restructurings, including those of Toys 'R' Us and SunGard Data Systems.

Anna Marie Wagner holds a Master of Business Administration from [Harvard Business School](/org/harvard-business-school), where they were a Baker Scholar (Highest Honors / Top 5% of Class), and a B.A. in Applied Mathematics in Economics from [Harvard University](/org/harvard), where they graduated cum laude.

Some of their coworkers include Matthew F. McKnight - General Manager, Biosecurity, Jennifer Wipf - SVP, Commercial Cell Engineering, and Greg LoConte - VP, Head of Infrastructure Operations. Their manager is Jason Kelly, Co-Founder & CEO.

Anna Marie Wagner

Reshma Shetty is a co-founder of [Ginkgo Bioworks](/org/ginkgo-bioworks). Prior to that, they were a graduate research assistant at the Massachusetts Institute of Technology in Tom Knight's lab in the Computer Science and Artificial Intelligence Laboratory. Reshma also worked as a research assistant at the [University of Cambridge](/org/university-of-cambridge) in Sir Tom Blundell's lab in the Department of Biochemistry and as an undergraduate research assistant at the [University of Utah](/org/university-of-utah) in Baldomero M. Olivera's lab in the Department of Biology.

Reshma Shetty received their Ph.D. in Biological Engineering from the Massachusetts Institute of Technology and their B.S. in Computer Science from the [University of Utah](/org/university-of-utah).

Reshma Shetty reports to Jason Kelly, Co-Founder & CEO. They work with Tomer Stavitsky - VP, Corporate Development, Head of M&A, Kevin Madden - SVP, Platform Commercialization, and Adithya Yaga - Head of Transformation.

Reshma Shetty

Jasmina Aganovic

Adithya Yaga joined Ginkgo Bioworks at the Head of Transformation in August 2022. Adithya is a seasoned executive with a 15+ year track record delivering transformational change on topics of strategy and operations across technology, retail, consumer, and industrial companies. Most recently, Adithya was the Chief Strategy Officer at LendingTree.

Adithya Yaga

Greg LoConte

Kalpesh Parekh

Jess Leber

Cornelis Mijnders

Angela Carisa Ailloni

Jennifer Wipf

Tomer Stavitsky

Aaron Huber

Chris Mellen

Marie Fallon

Susan A. Miele

Shyam Sankar is the current Director at [Ginkgo Bioworks](/org/ginkgo-bioworks). Shyam has also previously worked as the VP of Network Management for Asia Pacific at Xoom Corporation from January 2004 to March 2006, and as a Developer at ZeroChaos from June 2000 to January 2002.

Shyam Sankar is a graduate of [Stanford University](/org/stanford) and [Cornell University](/org/cornell-university). Shyam holds a BS in Electrical and Computer Engineering and an MS in Management Science and Engineering.

Shyam Sankar

Marijn Dekkers is the founder and chairman of Novalis LifeSciences LLC.

Marijn Dekkers

The current board of directors at Ginkgo Bioworks has a wide range of experience in both the public and private sector. Previous positions include CEO at Pacific Biosciences, Chairman of the Board at Wave Life Sciences, and Executive Vice President/Chief Commercial Officer at Illumina. In addition to experience in various industries, the board members also boast a diverse range of educational backgrounds from universities such as UC Irvine, Cornell University, and Stanford University.

Board of Directors

About

Team members

Other teams at Ginkgo Bioworks

Leadership Team

CEO and Executive Team

Discover similar companies